Dr. Maryam Hosseini | Immunotherapy Award | Best Researcher Award
Dr. Maryam Hosseini, Shiraz University of Medical Sciences, Iran
Publication profile
π¬ Education
Maryam’s research focuses on inflammation, cancer immunology, and immune therapy. Her doctoral thesis explored the role of exosome-enriched miRNA-34a from CT-26 cell lines in anti-tumor immune responses in colorectal cancer mouse models.
Awards
Maryam’s academic excellence is evident through numerous honors, including ranking first among MSc students and actively contributing to immunology committees in Iran.
π Teaching
Maryam is also dedicated to education, having taught immunology courses at Azad University. Her commitment extends to organizing international congresses and workshops, enriching both scientific discourse and student learning.
Research Focus
Publication Top Notes
- The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy
- Published: 2016 π
- Cited by: 90 π
- CAR-modified T-cell therapy for cancer: an updated review
- Published: 2016 π
- Cited by: 75 π
- Artificial intelligence in health: new opportunities, challenges, and practical implications
- Published: 2019 π
- Cited by: 51 π
- Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression
- Published: 2021 π
- Cited by: 33 π
- Assessment and estimating groundwater vulnerability to pollution using a modified DRASTIC and GODS models (case study: Malayer Plain of Iran)
- Published: 2018 π
- Cited by: 33 π
- Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition
- Published: 2021 π
- Cited by: 23 π
- Effect of clear corneal incision location on tear film following phacoemulsification surgery
- Published: 2009 π
- Cited by: 21 π
- The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer
- Published: 2022 π
- Cited by: 19 π
- Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
- Published: 2020 π
- Cited by: 19 π
- Recombinant LPG3 stimulates IFN-Ξ and TNF-A secretion by human NK cells
- Published: 2015 π
- Cited by: 18 π